CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Quantitative measurements the changes of IgG glycosylationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03394092
NCT03394092N/ACompleted
CompareCT.gov

Changes in Glycopeptides of Serum Immunoglobulin G in Patients With Acute Myocardial Infarction and the Relationships Between Its Change and Prognosis

The First Affiliated Hospital of Dalian Medical University·observational·Posted Jan 9, 2018·Updated Mar 19, 2019

In Brief

An observational study evaluating Quantitative measurements the changes of IgG glycosylation for Acute Coronary Syndrome. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The aim of this study is to investigate the changes in glycopeptides of serum immunoglobulin G in patients with acute myocardial infarction and the relationships between its change and prognosis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Coronary Syndrome
CountriesChina
CollaboratorsDalian Institute of Chemical Physics, Chinese Academy of Sciences , Dalian

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 9, 2018
Enrollment StartJan 15, 2018
Primary CompletionJan 15, 2019
Study CompletionMar 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 8.5 years ago

Interventions

Quantitative measurements the changes of IgG glycosylationother

Serum (50 each group) is obtained into ethylenediaminetetraacetic acid（EDTA） tubes from all subjects via antecubital venepuncture.Blood is obtained into ethylenediaminetetraacetic acid（EDTA） tubes from all subjects via antecubital venepuncture to assess the quantitative changes of IgG glycosylation by HPLC-MRM at 0 , 3 and 7 days after admission.